✦ LIBER ✦

Re: Sunitinib versus Interferon alfa in Metastatic Renal-Cell Carcinoma

✍ Scribed by Paul C.M.S. Verhagen

Book ID: 113609900
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 31 KB
Volume: 51
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2007.02.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib versus Interferon Alfa in Meta

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

✍ Motzer, Robert J.; Hutson, Thomas E.; Tomczak, Piotr; Michaelson, M. Dror; Bukow 📂 Article 📅 2007 🏛 Massachusetts Medical Society 🌐 English ⚖ 261 KB

Sunitinib versus Interferon Alfa in Meta

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

✍ Coplen, D.E. 📂 Article 📅 2008 🏛 Elsevier Science ⚖ 51 KB

Re: Pazopanib Versus Sunitinib in Metast

Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma

✍ Ouzaid, Idir; Rini, Brian 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Re: Pazopanib Versus Sunitinib in Metast

Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma

✍ Sun, Maxine; Trinh, Quoc-Dien; Perrotte, Paul; Karakiewicz, Pierre I. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 530 KB

Pazopanib versus Sunitinib in Metastatic

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

✍ Motzer, Robert J.; Hutson, Thomas E.; Cella, David; Reeves, James; Hawkins, Robe 📂 Article 📅 2013 🏛 Massachusetts Medical Society 🌐 English ⚖ 624 KB

246 OVERALL SURVIVAL WITH SUNITINIB VERS

246 OVERALL SURVIVAL WITH SUNITINIB VERSUS INTERFERON-ALFA (IFN-□) AS FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA (MRCC)

✍ C. Szczylik; S. Negrier; S. Oudard; R.A. Figlin; T.E. Hutson; P. Tomczak; M.D. M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 546 KB